Screening of novel molecules for SCA 17 treatment by using a microbial model
碩士 === 國立臺灣師範大學 === 生命科學研究所 === 97 === Abstract Many neurodegenerative diseases are linked to abnormally expanded CAG repeats in the coding regions of responsible genes. One of them, spinocerebellar ataxia type 17 (SCA 17) was identified with CAG trinucleotide repeat expansion in the TATA-box b...
Main Authors: | Che-Wei Shih, 史哲維 |
---|---|
Other Authors: | Guan-Chiun Lee |
Format: | Others |
Language: | zh-TW |
Published: |
2009
|
Online Access: | http://ndltd.ncl.edu.tw/handle/3pxg66 |
Similar Items
-
Screening of Novel Molecules for SCA 17 Treatment by Using a Microbial Model: Monitoring Protein Solubility by β-Galactosidase Structural Complementation
by: Hsin-Lan Kuo, et al.
Published: (2011) -
Screening of Novel Compounds and Oxidative Stress Studies using SCA17 Cell Model
by: Shih-Han Huang, et al.
Published: (2011) -
High-Throughput Microorganism-Based Screening of Novel Molecules for SCA 17 Treatment: Monitoring TBP solubility by chloramphenicol resistance
by: Zi-Ling Yong, et al.
Published: (2010) -
Identification of Neurotherapeutics for SCA17 Using Transgenic Mouse Model
by: Wang, Chien-Ming, et al.
Published: (2015) -
Evaluation of effect of HDAC inhibitors on SCA17 with SCA17 mouse slice culture and transgenic mice
by: Yu-Chen Tao, et al.
Published: (2013)